Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications for Clinical and Translational Science Awards (CTSA) Program consortium-wide resource centers that will rapidly demonstrate and disseminate to the wider consortium innovative resources (to include capabilities) that have established impact at a local or national level. Applications for CTSA consortium-wide centers are expected to rapidly demonstrate and disseminate resources to advance clinical and translational science efforts.

Only applications submitted in response to a Notice of Special Interest (NOSI) published by NCATS will be allowed to apply to this FOA.


  • Letter of Intent Due Date(s): 30 days prior to the application due date.

  • Application Due Date(s): June 21, 2022; June 21, 2023

PAR-22-122 Expiration Date New Date January 6, 2023 per issuance of NOT-TR-23-005. (Original Expiration Date: June 22, 2023 )

Agency Website

Eligibility Requirements

An application must be submitted by an institution that is a direct recipient of a CTSA Program hub or an institution listed as a partnering institution in a currently funded CTSA Program hub. A CTSA Program hub is defined as a UL1 award with a linked KL2 award and an optional TL1 award. A hub that is in no-cost extension (NCE) status is not considered a currently funded CTSA Program hub (see



Amount Description

Application budgets are limited to $3,000,000 per year direct cost and must reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period. The maximum project period is 5 years.

Funding Type





Medical - Clinical Science
Medical - Translational

External Deadline

June 21, 2022